• About
  • Meet The Team
  • Privacy Policy
Thursday, January 21, 2021

Stocks Telegraph
  • Login
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers
No Result
View All Result
Stocks Telegraph
No Result
View All Result

9 Meters Biopharma [NMTR] Breaks Monthly Resistance – Is A Rally Beckoning?

Company making progress in short bowel syndrome and Celiac disease treatments

by Nicholas K
August 20, 2020
in Featured, Investing
Share on FacebookShare on Twitter

9 Meters Biopharma [NASDAQ: NMTR] is showing some interesting price action. Yesterday, the stock gapped up and pushed through monthly support at $0.80. This price action came just a day after the company was highlighted at the Truist Securities Catalyst conference call. The conference call touched on preliminary phase 1 /2 data from short bowel syndrome that is expected in the second half of 2020. The highlight points to the progress that 9 Meters has made in the quest for a treatment for short bowel syndrome.

It also comes just a week after 9 Meters had provided an update on its treatment for the problem. In its update, the company stated that it had kick-started phase 1 ./2b clinical trial for its treatment adding that the first patients had been given a dose of the trial treatment in July, with the results expected in Q1 of 2021.

The company also stated that it had amended how it was defining the primary endpoint for its phase 3 trial for its celiac disease treatment.  It added that the amendment allowed for a reduction in the number of participants to 525 from the previous 630.  The update also highlighted that the company was anticipating multiple inflection points all through the next 18 months. While providing the update, CEO John Temperato stated that the company’s advances at the clinical trials have been good and that they were happy with the team.

 What next?

The stock has gained upside momentum after the release of this update indicating that investors are confident that the treatments could turn successful.  The excitement around this potential could see the stock keep gaining all through the year. Positive results from the trial in Q1 of 2021 could see the stock gain even further.

Besides, the excitement around the trials, there are several other factors that could see this stock keep gaining in value in the near-term.  One of them is that it has the finances to see its treatments succeed. The company recently gave an update for Q2 and stated that in the quarter, its cash and cash equivalents stood at $13.5 million. This was a significant increase compared to Q1 when it’s cash and cash equivalents stood at $2.7 million.  The company’s capability to see its programs through instills confidence in investors and could help support the price in the near-term.

Besides these internal factors, the markets have rebound despite the COVID-19 pandemic. There is lots of optimism that a COVID-19 vaccine could be available by the end of the year. Such a development could see NMTR, with all the positive vibe around it, gain all through the year.

About 9 Meters Biopharma

9 Meters Biopharma is a Biopharmaceutical Company that develops treatments for rare disorders. It is headquartered in Raleigh, North Carolina.

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

Tags: FeaturedInvestmentsNASDAQ: NMTRNMTR

Related Posts

Rekor Systems Inc [REKR] Is Just Getting Started on Gains
Featured

Gevo Stock in a dump mode following $350 million offerings, but buoyant in long-term

January 20, 2021
Tesla Inc. (NASDAQ: TSLA) Reportedly Discuss Nickel Supply Deal With Top Miner BHP
Featured

Alibaba (BABA) Stock comes to life after Jack Ma reappears; The potential prospect of BABA this year

January 20, 2021
Is Twilio (NYSE: TWLO) Stock A Buy?
Featured

All Hail Streaming King Netflix Inc. (NFLX)

January 20, 2021
Why Globus Maritime Limited (NASDAQ: GLBS) Stocks Soaring Today?
Featured

How will Coupa Software Inc (COUP) perform this year?

January 19, 2021
Top 20 Banking Industry Stocks For October 2020
Featured

Demand For Zoom Inc (ZM) Shares Overdid Company Expectations, Resulting In $2 Billion Sale

January 18, 2021
Top 15 Information Technology Stocks You Should Be Holding
Featured

Why Momo Inc (MOMO) Is Attracting Investors?

January 14, 2021
Next Post
Top 3 Reasons Why AzurRx Biopharma Inc [AZRX] is Gaining Bullish Momentum

High Potential Stocks to Watch Despite Weak Market Sentiment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Early Morning Vibes: The 4 Best Stocks To Buy Now

Blonder Tongue Receives U.S. Patent Grant For DMM Series Of Products
by Shan Zee
January 14, 2021
0

American stock markets ended trading largely in the green zone on January 13. The S&P 500 index improved to 3810...

Read more

Early Morning Vibes: Top 4 Stocks To Watch Right Now

Why Tesla Inc (NASDAQ: TSLA) Stock Might Be A Great Pick?
by Shan Zee
January 19, 2021
0

For Martin Luther King Day, the U.S. treasuries were closed yesterday. In the meantime, on Wednesday, the Americans are waiting...

Read more

Early Morning Vibes: 4 Stocks We Like for Friday

by Shan Zee
January 15, 2021
0

On January 14, the American stock indices closed in the red. The S&P 500 index dropped 0.38% to 3796 points,...

Read more

Early Morning Vibes: The 4 Best Stocks To Buy Now

9 Trending Stocks in Travel Services Industry That Can Be A Good Bets
by Shan Zee
January 20, 2021
0

On January 19, American stock indexes finished trading in the green zone. The S&P 500 Index rose 0.81% to 3799...

Read more

Early Morning Vibes: Watch These 4 Stocks Today

Beasley Broadcast Group (NASDAQ: BBGI) Announces Operating Results
by Shan Zee
January 13, 2021
0

The US stock indexes were traded in small ranges on January 12. The S&P 500 has risen symbolically by 0.04%...

Read more
  • About
  • Meet The Team
  • Privacy Policy

© 2020 Stocks Telegraph - All Rights Reserved

No Result
View All Result
  • Home
  • Featured
  • Investing
  • Morning News
  • Mid Day Movers

© 2020 Stocks Telegraph - All Rights Reserved

Welcome Back!

Login to your account below

Forgotten Password?

Create New Account!

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Get The Best Stocks To Trade Every Day!

Join now to get the Stockstelegraph.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.